EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort

Oumarou Nabi iD, Jonas Spaak, Göran Bergström iD, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi iD, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P Andersson iD, Hannes Hagström iD

Journal of Internal Medicine · 2026

DOI: 10.1111/joim.70071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Oumarou Nabi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population cohort. Methods From the Swedish CArdioPulmonary bioImage Study (SCAPIS) cohort, we analyzed 27,763 participants aged 50–64 years who underwent extensive clinical characterization. MASLD was defined as

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverHumansSwedenMaleMiddle AgedPrevalenceFemaleRisk FactorsLiver CirrhosisObesityDiabetes Mellitus, Type 2HypertensionCohort StudiesTomography, X-Ray Computed

Stichwörter der Autor:innen

MASLDadvanced fibrosisprevalence

Autor:innen und Institutionen

  • Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden.
  • Department of Clinical Physiology, Västra Götalandsregionen, Gothenburg, Sweden.
  • Department of Clinical Science in Malmö, Lund University, Lund, Sweden.
  • Department of Health, Medicine and Caring and Sciences, Linköping University, Linköping, Sweden.

ORCID-Profile: Oumarou Nabi, Göran Bergström, Andrei Malinovschi, Daniel P Andersson, Hannes Hagström

Förderung

  • The Swedish Research Council

Zitieren

APA

Nabi, O., Spaak, J., Bergström, G., Engström, G., Johan Östgren, C., Malinovschi, A., Kullberg, J., Blomberg, A., Jernberg, T., Andersson, D. P., & Hagström, H. (2026). Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. Journal of Internal Medicine. https://doi.org/10.1111/joim.70071

Vancouver

Nabi O, Spaak J, Bergström G, Engström G, Johan Östgren C, Malinovschi A, et al. Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. Journal of Internal Medicine. 2026. doi:10.1111/joim.70071

BibTeX
@article{Nabi2026,
  author = {Nabi, Oumarou and Spaak, Jonas and Bergström, Göran and Engström, Gunnar and Johan Östgren, Carl and Malinovschi, Andrei and Kullberg, Joel and Blomberg, Anders and Jernberg, Tomas and Andersson, Daniel P and Hagström, Hannes},
  title = {Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70071}
}
Kostenlos starten →